Form 8.3 – Warehouse REIT Plc
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full…
Monument veröffentlicht Finanzergebnisse für das zweite Quartal 2025
VANCOUVER, British Columbia, March 01, 2025 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY und FSE: D7Q1) „Monument“ oder das „Unternehmen“ gab heute seine Finanzergebnisse für die drei Monate („Q2…
ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger
All-Stock Transaction with Alumis Maximizes Long-Term Value for ACELYRIN Stockholders LOS ANGELES, March 04, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating…
Alumis and ACELYRIN Reaffirm Strategic and Financial Rationale of Proposed Merger
SOUTH SAN FRANCISCO, Calif. and LOS ANGELES, March 04, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS) (“Alumis”) and ACELYRIN, INC. (Nasdaq: SLRN) (“ACELYRIN”) today reaffirmed their commitment to merge…
ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger
Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS ANGELES and SOUTH SAN FRANCISCO, Calif., March 04, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq:…
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting…
49-Year Business Graphics 3 Sold to New Minuteman Press Franchise Owner Tyler Griffith in Coldwater, MI
COLDWATER, Mich., March 04, 2025 (GLOBE NEWSWIRE) -- Graphics 3, a second-generation printing business owned by Iveson family for 49 years, has been sold by retiring owner Mike Iveson to…
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
- Greatly improved patient quality of life and reduced disease impact in patients with CSU and CIndU -- 82% of CSU patients reported that symptoms no longer had an impact…
Notification of transaction by an Officer of Millicom (Tigo)
Notification of transaction by an Officer of Millicom (Tigo) Luxembourg, March 1, 2025 – Millicom International Cellular S.A. ("Millicom" or the “Company”) announces that, on February 27, 2025, under an…
TransPerfect Acquires Technicolor Games
SAN FRANCISCO and BANGALORE, India, March 01, 2025 (GLOBE NEWSWIRE) -- TransPerfect, the world’s largest provider of language and AI solutions for global business, today announced it has acquired Technicolor…